These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15719224)

  • 1. Reduced nicotine reward in obesity: cross-comparison in human and mouse.
    Blendy JA; Strasser A; Walters CL; Perkins KA; Patterson F; Berkowitz R; Lerman C
    Psychopharmacology (Berl); 2005 Jul; 180(2):306-15. PubMed ID: 15719224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine.
    Ray R; Jepson C; Patterson F; Strasser A; Rukstalis M; Perkins K; Lynch KG; O'Malley S; Berrettini WH; Lerman C
    Psychopharmacology (Berl); 2006 Oct; 188(3):355-63. PubMed ID: 16960700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diet-induced obesity causes ghrelin resistance in reward processing tasks.
    Lockie SH; Dinan T; Lawrence AJ; Spencer SJ; Andrews ZB
    Psychoneuroendocrinology; 2015 Dec; 62():114-20. PubMed ID: 26292268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking.
    Perkins KA; Doyle T; Ciccocioppo M; Conklin C; Sayette M; Caggiula A
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):600-7. PubMed ID: 16075290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitutes for tobacco smoking: a behavioral economic analysis of nicotine gum, denicotinized cigarettes, and nicotine-containing cigarettes.
    Johnson MW; Bickel WK; Kirshenbaum AP
    Drug Alcohol Depend; 2004 Jun; 74(3):253-64. PubMed ID: 15194203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm.
    Rukstalis M; Jepson C; Strasser A; Lynch KG; Perkins K; Patterson F; Lerman C
    Psychopharmacology (Berl); 2005 Jun; 180(1):41-8. PubMed ID: 15682300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments.
    Rose JE; Behm FM
    Nicotine Tob Res; 2004 Jun; 6(3):523-32. PubMed ID: 15203786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adolescent nicotine or cigarette smoke exposure changes subsequent response to nicotine conditioned place preference and self-administration.
    de la Peña JB; Ahsan HM; Botanas CJ; Sohn A; Yu GY; Cheong JH
    Behav Brain Res; 2014 Oct; 272():156-64. PubMed ID: 24991754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mu-opioid receptor and CREB activation are required for nicotine reward.
    Walters CL; Cleck JN; Kuo YC; Blendy JA
    Neuron; 2005 Jun; 46(6):933-43. PubMed ID: 15953421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking modulation of mu-opioid and dopamine D2 receptor-mediated neurotransmission in humans.
    Scott DJ; Domino EF; Heitzeg MM; Koeppe RA; Ni L; Guthrie S; Zubieta JK
    Neuropsychopharmacology; 2007 Feb; 32(2):450-7. PubMed ID: 17091130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional Upregulation of α4* Nicotinic Acetylcholine Receptors in VTA GABAergic Neurons Increases Sensitivity to Nicotine Reward.
    Ngolab J; Liu L; Zhao-Shea R; Gao G; Gardner PD; Tapper AR
    J Neurosci; 2015 Jun; 35(22):8570-8. PubMed ID: 26041923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant mesolimbic dopamine-opiate interaction in obesity.
    Tuominen L; Tuulari J; Karlsson H; Hirvonen J; Helin S; Salminen P; Parkkola R; Hietala J; Nuutila P; Nummenmaa L
    Neuroimage; 2015 Nov; 122():80-6. PubMed ID: 26260431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Translational control of nicotine-evoked synaptic potentiation in mice and neuronal responses in human smokers by eIF2α.
    Placzek AN; Molfese DL; Khatiwada S; Viana Di Prisco G; Huang W; Sidrauski C; Krnjević K; Amos CL; Ray R; Dani JA; Walter P; Salas R; Costa-Mattioli M
    Elife; 2016 Mar; 5():. PubMed ID: 26928076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of alcohol on responses to nicotine-containing and denicotinized cigarettes in dependent and nondaily smokers.
    Barrett SP; Campbell ML; Roach S; Stewart SH; Darredeau C
    Alcohol Clin Exp Res; 2013 Aug; 37(8):1402-9. PubMed ID: 23527868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cigarette smoke exposure during adolescence enhances sensitivity to the rewarding effects of nicotine in adulthood, even after a long period of abstinence.
    de la Peña JB; Ahsan HM; Tampus R; Botanas CJ; dela Peña IJ; Kim HJ; Sohn A; dela Peña I; Shin CY; Ryu JH; Cheong JH
    Neuropharmacology; 2015 Dec; 99():9-14. PubMed ID: 26116818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET studies of the influences of nicotine on neural systems in cigarette smokers.
    Rose JE; Behm FM; Westman EC; Mathew RJ; London ED; Hawk TC; Turkington TG; Coleman RE
    Am J Psychiatry; 2003 Feb; 160(2):323-33. PubMed ID: 12562580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol reduces smoking of both nicotine-containing and denicotinized cigarettes.
    Brauer LH; Cramblett MJ; Paxton DA; Rose JE
    Psychopharmacology (Berl); 2001 Dec; 159(1):31-7. PubMed ID: 11797066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mu opioid receptor knockdown in the substantia nigra/ventral tegmental area by synthetic small interfering RNA blocks the rewarding and locomotor effects of heroin.
    Zhang Y; Landthaler M; Schlussman SD; Yuferov V; Ho A; Tuschl T; Kreek MJ
    Neuroscience; 2009 Jan; 158(2):474-83. PubMed ID: 18938225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CREB1 haplotypes and the relative reinforcing value of nicotine.
    Ray R; Jepson C; Wileyto P; Patterson F; Strasser AA; Rukstalis M; Perkins K; Blendy J; Lerman C
    Mol Psychiatry; 2007 Jul; 12(7):615-7. PubMed ID: 17592483
    [No Abstract]   [Full Text] [Related]  

  • 20. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Morton LM; Wang SS; Bergen AW; Chatterjee N; Kvale P; Welch R; Yeager M; Hayes RB; Chanock SJ; Caporaso NE
    Pharmacogenet Genomics; 2006 Dec; 16(12):901-10. PubMed ID: 17108814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.